Liquid Dosage
Antibiotics, compounds or substances that combat bacterial infections and kill or slow down their growth, comprise one of the most important groups of drugs in the fight against infectious diseases. Representing around 13% of total pharmaceutical consumption, they have the highest market share of any pharmaceutical product.
In liquid-based applications, the pharmaceutical industry extracts antibiotics from fermentation broths. GEA supports this process with special decanters that facilitate the process, offering efficient direct extraction solutions that are also environmentally friendly.
Extraction essentially consists of two combined processes: mixing and separating. GEA has developed a patented decanter that combines the two process steps in a single machine to enhance the extraction of active ingredients.
This decanter allows suspensions with a high solids content to be processed, rendering them suitable for direct antibiotic extraction from the culture solution (which often has a high mycelium content). The previously essential filtration step is no longer required, which not only makes the process continuous, it also prevents the loss of valuable material that was frequently associated with filtration.
Offering increased total yields of up to 98% compared with conventional counter-current extraction, direct extraction is also significantly more cost-effective (no filter aids are needed). The fermentation broth itself is not diluted by filter wash water, which both reduces the solvent requirement and the risk of infection. In addition, the optimized procedure also reduces wastewater pollution and the actual volume of wastewater produced.
Driven by new product innovations, high levels of R&D investment and the pharmaceutical industry’s need to ameliorate the issue of antibiotic resistance, the antibiotic market is expected to show continued growth. From R&D-scale and standalone manufacturing equipment to completely integrated process lines that maximize operational reliability, GEA supplies a complete range of equipment and solutions for the industrial-scale production of antibiotics, antibacterials and anti-infectives.
يتم عرض 4 من 15

GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.

GEA's versatile range of R&D drying & particle processing equipment - for advanced powder processing within food and dairy products, chemicals and pharmaceuticals.

يُعد التصميم والتطوير وإنتاج نظم التحميل والتفريغ للاستخدامات في العديد من الصناعات هو الأختصاص الأساسي لمجموعة GEA. ومهما كان المنتج أو العملية، فإن الحلول القياسية أو المصممة حسب الحاجة، سواء كانت تعمل يدويًا أو مؤتمتة بالكامل، يمكن بناؤها وتسليمها لتلبية الاحتياجات الفردية لعملائنا.

تواجه صمامات التعقيم مطالب عالية بشكل استثنائي داخل العمليات فائقة النظافة وعمليات التعقيم. وبما أن سلامة المنتج والعملية تحظى بأولوية قصوى ضمن هذه التطبيقات، فقد تم تجهيز صماماتنا بعنصر ختم محكم لتجنب دخول الكائنات الحية الدقيقة إلى عملية معقمة. ومع ثلاث خطوط من الصمامات المختلفة، نقدم المكون المثالي لجميع أنواع التطبيقات والتفضيلات الشخصية. يمك...
Whether it’s a fad or the future, 100% vial traceability is becoming an increasingly important consideration in the pharmaceutical freeze drying industry. Keeping a close eye on developments is GEA. We’re investigating possible solutions and, what’s more, we have the experience, expertise and know-how to implement them.
كان هناك وقت حيث من النادر استخدام عبارتي "بيرة خالية من الكحول" و "طعمها جيد" معًا في الجملة نفسها، خاصة من قبل المستهلكين. ولكن قطعت البيرة منخفضة الكحول والبيرة الخالية من الكحول شوطًا طويلًا - وأصبح الكثير منها الآن مشروبات منعشة في حد ذاتها - بفضل جزء صغير من تكنولوجيا GEA.
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.